General

Learn about the state-of-the-art in oncological imaging
all from the comfort of your home or workplace!

Since 2015, ESOI has been proudly offering high quality webinars given by world class speakers on various topics in oncologic imaging. Our live webinars have been very well received by our members with consistently high turnout and engagement from participants all across the globe. After the presentation, you can even ask questions in real time!

ESOI webinars are oriented towards different levels of expertise, a wide array of topics, and are increasingly becoming more multidisciplinary.
A number of our webinars are carried out in collaboration with medical societies such as ESSO and ESTRO as well as other radiological subspecialty societies.
Young radiologists are also included in the webinar series with special sessions addressing relevant topics for residents.

In addition to the live broadcast, the lectures are uploaded to the Member Area (with an approximate one month delay) so they can be (re)viewed by active ESOI members at their own convenience.
To date, we have more than 70 full length lectures (with in-depth discussions and Q&A)!

Recommended Bandwidth
The website www.speedtest.net offers you to check your bandwidth. We strongly recommend
• Upload min. 6Mbit required bandwidth (relevant for speakers, moderators sharing their video&audio signal)
• Download min. 6Mbit required bandwidth
Also, we recommend a cable internet or a wireless connection with full signal.
Please note: Shared bandwidth (e.g. hospital, universities) will result in lower bandwidth for each user.

Organisers

M. D’Anastasi, Msida/MT
D. Regge, Turin/IT
G. Zamboni, Verona/IT
.

Official Partner

 

 

 

Webinar Certificate 2021

ESOI offers a certificate to active participants of the webinar series.
To qualify, active ESOI full / allied sciences members must attend a minimum of seven (7) webinars in 2021.
ESOI resident members must attend the two (2) dedicated Young Radiologists Webinars on top of six (6) other webinars, so a total of eight (8) webinars.

In addition to attending the live webinars, the assessment questions following each individual webinar must be completed directly after the live session. To obtain the certificate, at least 70% of the submitted questions must be answered correctly.

Please note

  • The assessment questions will only show after the live sessions. There will be no other opportunity to evaluate and submit your answers.
  • The certificate will be issued at the beginning of 2022.
  • The webinars are not CME accredited.
  • ESOI does not issue individual certificates of attendance for the webinars.
Webinar Testimonial – Harish N.

“During this pandemic era, I am very thankful to ESOI a society which is dedicated to educating the oncology professionals across the border with their experts delivering lectures through webinars mainly focussing on challenging and innovative topics in oncological imaging, which helps in better management of the cancer patients.”

Harish N. from Nairobi, Kenya attended 9 ESOI webinars in 2020

Webinar Testimonial – Ludovit S.

“If you are thinking about joining ESOI I can only recommend it. The year 2020 was challenging and the society really helped me to cope with these demanding circumstances, not only in cancer diagnostic, but with the management of patients in the context of the pandemic. The webinars and Q&A helped to lessen the need of personal interactions with renowned doctors in the field of cancer diagnostics and insights how to manage patient flow in the shadow of a contagious disease were useful too. I wish everyone the strength to overcome difficulties yet to come and hope to see everyone well and healthy at the next OIC.”

Ludovit S. from Dunajska Streda, Slovakia attended 11 ESOI webinars in 2020

Upcoming Webinar

Webinar #3: ESOI-ESHI-MT: AI in multimodality imaging of cancer
Clemes Cyran, Munich/DE
Wednesday, March 17, 2021 | 18:00 CET

Multimodality diagnostic imaging aims to characterize tumor pathophysiology by integrating multidimensional complementary data using morphological, functional and molecular features. Hybrid imaging with multitracer PET and multiparametric MRI demonstrate great potential for non-invasive tumor phenotyping and the characterization of underlying pathophysiological processes with multimodality-based models beyond morphological analysis and classical texture features. Major challenges remain with regard to the preprocessing of multimodality images, for fusion algorithms in combining data at feature level, classifier level or decision level as well as the appropriate choice of the learning model. High potential DNN (deep-learning neural networks) without feature designing process, however, are very data hungry projecting towards structured image data biobanks and present increased complexity with the design of optimal models. From a systematic perspective, particular challenges arise how multi representations can be fused and explored most effectively. The implementation of automated multimodality cancer imaging could proof as a highly effective diagnostic method, carrying the potential to significantly reduce morbidity and mortality by optimized therapy guidance in cancer. The integration of efficient diagnostic tools based on multimodality hybrid imaging into comprehensive clinical algorithms in cancer has the potential to significantly lower therapeutic costs. The anticipated socio-economic impact of powerful diagnostic data on our healthcare systems promotes the forthcoming of integrated diagnostics by healthcare providers that will demand this concept as a prerequisite in line with the implementation of population-based pay-4-performance reimbursement systems.

• To learn about functional and molecular imaging methods that contribute to the non-invasive characterization of tumor pathophysiology in vivo beyond morphology
• To get acquainted with the current AI applications in multimodality cancer imaging for integrating morphological, functional and molecular parameters to guide tumor therapy
• To discuss the key challenges how multi representations of imaging parameters are fused and explored most effectively to provide a structured medical imaging data stream towards integrated diagnostics

Prof. Dr. Clemens Cyran is Professor of Radiology at the Faculty of Medicine and Vice Chair of the Department of Radiology of the Ludwig-Maximilians-University Munich, Germany. After graduation from Medical School in Munich, Prof. Cyran assumed a position as postdoctoral research fellow at the Center for Pharmaceutical and Molecular Imaging, University of California San Francisco, from 2006 to 2007 with a research focus on imaging biomarkers of therapy response in experimental oncology. Prof. Cyran completed his residency in radiology in Munich in 2013 and is also board certified in diagnostic nuclear medicine.

Between 2017 and 2019 Prof. Cyran served as vice chair of the Department of Radiology at the Ludwig-Maximilians-University Munich and was section chief of the hybrid imaging department. Following a period in private practice, Prof. Cyran returned to academia in July 2020 reassuming his position as Vice Chair at the Department of Radiology at the Ludwig-Maximilians-University Munich.

The research focus of Prof. Cyran is the development and validation of imaging biomarkers of therapy response in oncology using multimodality hybrid imaging techniques, including MRI, multi-tracer PET and optical fluorescence imaging, with a strong translational focus. Current projects investigate methods of automated image analysis of digital molecular imaging data using artificial intelligence based algorithms as well as AI-based analytics for multidisciplinary diagnostic data in integrated diagnostics.

Who can register for this webinar and how?
This webinar is offered to active ESOI and ESHI-MT members only.

Your registration will therefore only be accepted upon verification of your active membership with either one society.
Please find all information about ESOI membership here: ESOI 2021 Membership

In order to register as ESOI member, please use this link: Webinar Registration
ESHI-MT members will receive the special registration link from their Office.

Should you be in doubt of your current membership status, please contact the ESOI Office at office@esoi.society.org.

Webinars Overview

Further Webinars 2021

Find below a list of all planned live webinars in 2021 in addition to those mentioned above! Details will be shared a few weeks before the respective lecture.

More Webinars 2021

Webinar #4

Multidisciplinary & young radiologists webinar
Preoperative assessment of peritoneal carcinomatosis

Stephanie Nougaret, Francois Quenet; Montpelllier/FR
Wednesday, April 07, 2021 | 18:00 CEST

 

Webinar #5

NET: How to assess response to therapy – A case-based multidisciplinary discussion
Young radiologists webinar

Damiano Caruso, Maria Rinzivillo; Rome/IT (case presenters)
Francesco Panzuto, Rome/IT; Massimo Falconi, Milan/IT (panelists)
Andrea Laghi, Rome/IT (moderator)
Thursday, May 06, 2021 | 18:00 CEST

 

Webinar #6

Preparing and attending oncologic MDT meetings: A memorandum for the radiologist
Laure Fournier, Paris/FR
Monday, June 14, 2021 | 18:00 CEST

 

Webinar #7

ESOI-EUSOBI: Surveillance after breast cancer treatment
Kristina Lang, Lund/SE
Thursday, July 01, 2021 | 18:00 CEST

 

Webinar #8

Urologic webinar:
– Penile cancer: Role of MRI in the new 8th TNM staging system
– Testicular germ cell tumors: Staging and surveillance
Alberto Vargas, Sungmin Woo, Anton Becker; New York/US
Thursday, August 05, 2021 | 18:00 CEST

 

Webinar #9

ESOI-ESNR: Brain metastases: Imaging after treatment
Ana Ramos, Madrid/ES
Tuesday, September 28, 2021 | 18:00 CEST

 

Webinar #10

ESOI-ESTI: Pulmonary complications in oncologic therapy – What the oncologic radiologist must know
Cornelia Schaefer-Prokop, Amersfoort/NL
Wednesday, October 27, 2021 | 18:00 CEST

 

Webinar #11

Imaging of HCC:
– Radiomics and radiogenomics in HCC (Emanuele Neri, Pisa/IT)
– Assessment of HCC response to therapy: New treatments, new challenges, new criteria (Riccardo Lencioni, Pisa/IT)
Tuesday, November 16, 2021 | 18:00 CET

 

Webinar #12

Imaging-pathology characterisation of ovarian masses: The good, the bad and the ugly
Evis Sala, Mercedes Jimenez-Linan; Cambridge/UK
Tuesday, December 07, 2021 | 18:00 CET

 

Kindly note that this programme is subject to possible modifications and will be updated here accordingly.

Previous Webinars

Find below comprehensive overviews of our previous webinar topics, year by year (2015-2020), to understand what we offer our active members in the form of recorded online lectures!

Previous Webinars 2021

Webinar #1: ESOI-ESSO-ESTRO: Rectal Cancer: A multi-disciplinary approach to imaging

R. Beets-Tan (Radiologist), G. Beets (Surgeon), C. Marijnen (Radiation oncologist); Amsterdam/NL

 

Webinar #2: Imaging of lymphomas: Current status

M. Mayerhöfer, New York/US

Previous Webinars 2020

Limits and pitfalls of CT and MR in the staging of lung cancer

J. Dinkel, Munich/DE

 

Uterine tumours: Correlation between histology and imaging features

E. Sala (Radiologist), M. Jimenez-Linan (Pathologist); Cambridge/UK

 

A practical approach for the diagnosis of a liver tumor

V. Vilgrain, Paris/FR

 

Tumour board: GEP-NET

A. Laghi (Radiologist), D. Caruso (Radiologist), F. Panzuto (Gastroenterologist), M. Rinzivillo (Gastroenterologist); Rome/IT
M. Falconi, Milan/IT (Surgeon)

 

MSK – soft tissues tumours

F. Vanhoenacker, Antwerp/BE

 

Role of cardiac imaging (CT and MRI) in patients with cancer

B. Velthuis, Utrecht/NL

 

Spinal tumours

L. van den Hauwe, Antwerp/BE

 

Imaging biomarkers in oncology

A. Alberich-Bayarri, Valencia/ES

 

Multidisciplinary Webinar from ESOI-ESTRO
Lung cancer: A multidisciplinary approach to imaging

A.R. Larici (Radiologist), V. Valentini (Radiation Oncologist); Rome/IT

 

Oncologic Imaging and Covid-19: An unwanted wedding

D. Regge, Turin/IT; D. Caruso, Rome/IT

 

Imaging in gastric cancer before and after neoadjuvant therapy

M.A. Mazzei, Siena/IT

 

ESOI Young Radiologists’ Webinar: Basic statistics

M. Maas, Amsterdam/NL

Previous Webinars 2019

Prostate cancer: A multidisciplinary approach to imaging

H-P. Schlemmer (Radiologist), J.P. Radtke (Urologist); Heidelberg/DE

 

Immune therapy: Response assessment and toxicity

D. Regge, Turin/IT

 

Small bowel tumours

M. Gollub, New York/US

 

Interventional oncological options for RCC

M. Krokidis, Cambridge/UK

 

Rectal cancer: A multidisciplinary approach to imaging

R. Beets-Tan, Amsterdam/NL (Radiologist), N. Figueiredo, Lisbon/PT (Surgeon), R. Glynne-Jones, Northwood/UK (Radiation Oncologist)

 

Imaging and response assessment of multiple myeloma

A. Baur-Melnyk, Munich/DE

 

Artificial intelligence in oncologic imaging: Current status and future directions

E. Neri, Pisa/IT (Radiologist); A. Alberich Bayarri, Valencia/ES (Telecommunications Engineer)

 

Clinical relevance of PSMA PET/CT: An overview and update

C. Cyran, Munich/DE

 

Assessing response to therapy of brain tumours

P.M. Sundgren, Lund/SE

 

Pancreatic cancer: A multidisciplinary approach to imaging

G. Zamboni (Radiologist), G. Marchegiani (Surgeon); Verona/IT

 

Breast cancer: A multidisciplinary approach to imaging in neoadjuvant treatment

M. Lobbes, Sittard-Geleen/NL (Radiologist); M.L. Smidt, Maastricht/NL (Surgeon)

 

Interventional oncological treatment of lung nodules/lung cancer

J. Palussière, Bordeaux/FR

 

New paradigms in scientific publishing

M.F. Reiser, Munich/DE

 

Correlation of radiological images with surgical findings in ovarian peritoneal disease

L. Fournier (Radiologist), A.S. Bats (Surgeon); Paris/FR

Previous Webinars 2018

Rectal Cancer: A multidisciplinary approach to imaging

R. Beets-Tan (Radiologist), G. Beets (Surgeon), B. van Triest (Radiation oncologist); Amsterdam/NL

 

Cross-sectional imaging of renal tumours

R. Pozzi Mucelli, Verona/IT

 

Structured reporting in prostate cancer

D. Regge, Turin/IT

 

Imaging of testicular tumours

M. Bertolotto, Trieste/IT

 

Preoperative local staging of breast cancer: tailoring the surgical treatment

J. Camps Herrero, Alzira/ES (Radiologist); R. Ponzone, Turin/IT (Surgeon)

 

Response evaluation in oncology: RECIST 1.1

M. D’Anastasi, Msida/MT

 

Algorithmic approach to the female pelvic mass

E. Sala, Cambridge/UK

 

Molecular and hybrid imaging in prostate cancer

G. Cook, London/UK

 

Rectal cancer: A multidisciplinary approach to imaging

R. Beets-Tan (Radiologist), G. Beets (Surgeon), B. van Triest (Radiation oncologist); Amsterdam/NL

 

Diagnosis and staging of oesophageal and gastric cancer

M. Laniado, Dresden/DE

 

Neuroendocrine tumours – radionuclide imaging and therapy

H. Ilhan, Munich/DE

 

Structured reporting in rectal cancer

M. Maas, Amsterdam/NL

 

Imaging after treatment of lung cancer

J. Dinkel, Munich/DE

 

Multidisciplinary management of CRC liver metastases

Th. Helmberger, Munich/DE

 

Lung cancer screening – what did we learn so far?

C. Schaefer-Prokop, Amersfoort/NL

 

Assessment of the treatment response of bone lesions in cancer patients: Pearls and pitfalls

F. Lecouvet, Brussels/BE

 

Imaging and response assessment of gastrointestinal stromal tumours

A. Laghi, Rome/IT

Previous Webinars 2017

Imaging of CNS tumours

P. Parizel, Antwerp/BE

 

Imaging and differential diagnosis of orbital tumours

U. Mueller-Lisse, Munich/DE

 

Imaging of lymphomas

M. Mayerhöfer, Vienna/AT

 

Imaging spectrum of primary and secondary mesenteric neoplasms

S. Nougaret, Montpellier/FR

 

Imaging of the treated pelvis: Pearls and pitfalls

E. Sala, New York/US

 

MR imaging of malignant diseases of the uterus

Y. Lakhman, New York/US

 

Practical advice in preparing successful scientific manuscripts

M.F. Reiser, Munich/DE

 

Imaging of recurrent prostate cancer

H. Vargas, New York/US

 

Bone metastases, how should we approach them with imaging?

T. Bäuerle, Erlangen/DE

 

PET-MRI in oncologic imaging – where do we stand?

V. Goh, London/UK

 

When to call a lesion an HCC?

G. Brancatelli, Palermo/IT

 

Current evidence for minimally invasive treatments in HCC

J. Ricke, Munich/DE

 

Diagnostic test studies: How I do it

M. Maas, Amsterdam/NL

 

Paediatric abdominal tumours

C. Granata, Genoa/IT

Previous Webinars 2016

Staging of rectal cancer with MRI

R. Beets-Tan, Amsterdam/NL

 

Contrast-enhanced ultrasound-technical considerations and applications in oncologic imaging

D. Clevert, Munich/DE

 

Imaging dissemination pathways in head and neck cancer

M. Mack, Munich/DE

 

Whole body MRI in onology

V. Vandecaveye, Leuven/BE

 

Imaging of lung cancer: Implications on management

L. Bonomo, Rome/IT

 

Imaging of biliary tract tumours

R. Manfredi, Verona/IT

 

Staging of ovarian cancer – providing a GPS to patient management

H. Hricak, New York/US

 

Role of MRI in the diagnosis and management of prostate cancer

H. Vargas, New York/US

 

Tailoring breast imaging surveillance to the woman´s risk

F. Gilbert, Cambridge/UK

 

Imaging of bone tumours

G. Guglielmi, Foggia/IT

 

RECIST, CHOI and beyond

M. D’Anastasi, Munich/DE

Previous Webinars 2015

DW in oncologic imaging

D. Lambregts, Maastricht/NL

 

CT colonography

A. Laghi, Latina/IT

 

Cystic and solid pancreatic tumors

G. Zamboni, Verona/IT

 

Imaging the prostate – current status and future developments

J. Futterer, Nijmengen/NL

 

Update on breast MRI

F. Sardanelli, Milan/IT

 

Structured oncologic reporting

W. Sommer, Munich/DE

Webinar Recordings

Stay up-to-date in oncological imaging and enjoy unlimited access to a vast array of lectures from world leaders in their field!

ESOI webinars are recorded and made available to our active members (after a period of approximately 30 days).
To date, there are more than 60 full length recorded lectures available. In order to see which webinars have been organised in the past, please refer to the Webinar Overviews above. In addition, below is a preview of some lectures that are available.

In order to access the recordings via the link below, please make sure your membership 2021 is active and that you are logged in (members area – right upper corner).

Webinar recordings